Myolastan Side Effects

Common Myolastan Side Effects

The most commonly reported Myolastan side effects (click to view or check a box to report):

Dermatitis Contact (2)
Abasia (1)
Dizziness (1)
Fatigue (1)
Agranulocytosis (1)
Altered State Of Consciousness (1)
Bradycardia (1)
Bone Marrow Failure (1)
Asthenia (1)
Feeling Abnormal (1)
Prostate Cancer Stage Ii (1)
Hypersensitivity (1)
Haemorrhagic Stroke (1)
Grand Mal Convulsion (1)
Lung Disorder (1)
Macule (1)
Pneumonia (1)
Musculoskeletal Stiffness (1)
Malaise (1)
Pyrexia (1)

➢ More

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Myolastan Side Effects Reported to FDA

The following Myolastan reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

The appearance of Myolastan on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Bone Marrow Failure
This is a report of a 69-year-old female patient (weight: NA) from FR, suffering from the following symptoms/conditions: NA, who was treated with Myolastan (dosage: NA, start time: NS), combined with:
  • Torental Lp
  • Naprosyn
and developed a serious reaction and side effect(s). The consumer presented with:
  • Bone Marrow Failure
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Myolastan treatment in female patients, resulting in bone marrow failure side effect.

Prostate Cancer Stage Ii
This report suggests a potential Myolastan Prostate Cancer Stage Ii side effect(s) that can have serious consequences. A male patient (weight: NA) from FRANCE was diagnosed with the following symptoms/conditions: muscle spasms,chronic obstructive pulmonary disease,multiple myeloma and used Myolastan (dosage: 25 Milligram;) starting Sep 01, 2009. Soon after starting Myolastan the patient began experiencing various side effects, including:
  • Prostate Cancer Stage Ii
Drugs used concurrently:
  • Spiriva (18 Microgram;)
  • Dexamethasone
  • Lenalidomide
  • Maxair
  • Symbicort
  • Lytos (1040 Milligram;)
  • Lenalidomide
  • Previscan (20 Milligram;)
Although Myolastan demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as prostate cancer stage ii, may still occur.

Bronchopulmonary Aspergillosis, Pneumonia
This Bronchopulmonary Aspergillosis, Pneumonia problem was reported by a physician from FRANCE. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Mar 07, 2011 this consumer started treatment with Myolastan (dosage: 50 Mg, Unk). The following drugs were being taken at the same time:
  • Imatinib Mesylate (400 Mg, Bid)
  • Bactrim (1400 Mg, Qw)
  • Granocyte (34 Ui, Unk)
  • Methotrexate (1500 Mg, Qd)
  • Cytarabine (4700 Mg, Bid)
  • Lutenyl (3 Mg, Unk)
  • Valacyclovir Hydrochloride (1500 Mg, Unk)
When commencing Myolastan, the patient experienced the following unwanted symptoms/side effects:
  • Bronchopulmonary Aspergillosis
  • Pneumonia
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as bronchopulmonary aspergillosis, may become evident only after a product is in use by the general population.

Macule, Agranulocytosis
This is a report of a 25-year-old male patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: NA and was treated with Myolastan (dosage: NA) starting Jul 04, 2011. Concurrently used drugs:
  • Athymil
  • Nexium
  • Eductyl
  • Tienam
  • Rocephin
  • Ditropan
  • Claforan
  • Cefepime Hydrochloride
Soon after that, the consumer experienced the following side effects:
  • Macule
  • Agranulocytosis
This opens a possibility that Myolastan treatment could cause the above reactions, including macule, and some male subjects may be more susceptible.

Lung Disorder, Hypersensitivity, Pyrexia
A 52-year-old female patient (weight: NA) from FRANCE with the following symptoms/conditions: NA started Myolastan treatment (dosage: 50 Mg) on Aug 25, 2011. Soon after starting Myolastan treatment, the subject experienced various side effects, including:
  • Lung Disorder
  • Hypersensitivity
  • Pyrexia
Concurrently used drugs:
  • Rovamycin (1 500 000 Ui)
  • Morphine Sulfate (10 Mg)
  • Keppra (Unk)
  • Primperan Tab (10 Mg)
  • Augmentin (500/62.5 Mg)
  • Acupan (Unk)
  • Potassium Chloride (Unk)
  • Nicardipine Hcl
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Myolastan.

Asthenia, Bradycardia, Dizziness
A 63-year-old female patient from SPAIN (weight: NA) experienced symptoms, such as: NA and was treated with Myolastan(dosage: NA). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Asthenia
  • Bradycardia
  • Dizziness
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Myolastan efficacy:
  • Nolotil
  • Tramadol Hcl

Feeling Abnormal, Fatigue, Abasia, Musculoskeletal Stiffness, Burning Sensation
In this report, Myolastan was administered for the following condition: NA.A 62-year-old female consumer from FRANCE (weight: NA) started Myolastan treatment (dosage: Unk) on Jan 01, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Feeling Abnormal
  • Fatigue
  • Abasia
  • Musculoskeletal Stiffness
  • Burning Sensation
A possible interaction with other drugs could have contributed to this reaction:
  • Solu-medrol (1 G, 1x/day)
  • Stilnox (Unk)
  • Dafalgan
  • Cymbalta (Unk)
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Myolastan treatment could be related to the listed above side effect(s).

Altered State Of Consciousness, Malaise, Haemorrhagic Stroke, Cerebral Haematoma, Cerebral Haemorrhage
This is a report of the following Myolastan side effect(s):
  • Altered State Of Consciousness
  • Malaise
  • Haemorrhagic Stroke
  • Cerebral Haematoma
  • Cerebral Haemorrhage
A female patient from FRANCE (weight: NA) presented with the following condition: NA and received a treatment with Myolastan (dosage: NA) starting: Mar 11, 2010.The following concurrently used drugs could have generated interactions:
  • Acetaminophen
  • Arixtra (2.5mg Per Day)
  • Low Molecular Weight Heparin
The patient was hospitalized.This report suggests that a Myolastan treatment could be associated with the listed above side effect(s).

Dermatitis Contact
This Myolastan report was submitted by a 51-year-old female consumer from BELGIUM (weight: NA). The patient was diagnosed with: NA and Myolastan was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Dermatitis Contact
Other drugs used simultaneously:
  • Lorazepam
Those unexpected symptoms could be linked to a Myolastan treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Dermatitis Contact
This is a report of a possible correlation between Myolastan use and the following symptoms/side effect(s):
  • Dermatitis Contact
which could contribute to an assessment of Myolastan risk profile.A 39-year-old male consumer from BELGIUM (weight: NA) was suffering from NA and was treated with Myolastan (dosage: NA) starting NS.Other concurrent medications:
  • Zolpidem
  • Lorazepam

Grand Mal Convulsion
A 61-year-old male patient from FRANCE (weight: NA) presented with the following symptoms: NA and after a treatment with Myolastan (dosage: NA) experienced the following side effect(s):
  • Grand Mal Convulsion
The treatment was started on Feb 11, 2009. Myolastan was used in combination with the following drugs:
  • Zolpidem
  • Botox
  • Baclofen
  • Deroxat
  • Lovenox
  • Perindopril
  • Xatral
  • Sintrom
This report could alert potential Myolastan consumers.

In this report, a male patient from FRANCE (weight: NA) was affected by a possible Myolastan (tetrazepam) side effect.The patient was diagnosed with conversion disorder,paraplegia. After a treatment with Myolastan (tetrazepam) (dosage: 50 Mg, start date: NS), the patient experienced the following side effect(s):
  • Talipes
The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Myolastan (tetrazepam) treatment.

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Myolastan Side Effects

    Did You Have a Myolastan Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor

    How Effective is Myolastan for You?

    Exceeded Expectations
    Somewhat Effective
    Not Effective

    Myolastan Safety Alerts, Active Ingredients, Usage Information

    More About Myolastan

    Side Effects reported to FDA: 12

    Myolastan safety alerts: No

    Reported deaths: 2

    Reported hospitalizations: 3

    Latest Myolastan clinical trials

    Myolastan Reviews

    No reviews, be a first to report a side effect via side effect reporting form